Inaktiver Wert

pSivida Co. Aktie Australian S.E.

Aktien

Dauer

Zeitraum

Stil

EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information	19.04.18
EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™	12.04.18
PSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.	28.03.18
PSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis	19.03.18
PSivida To Present at the 30th Annual ROTH Conference	05.03.18

Sektor